Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

PALI Palisade Bio Inc

5,85

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:00:02

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

Palisade Bio (NASDAQ:PALI)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Palisade Bio Charts.

Palisade Bio (NASDAQ:PALI)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Palisade Bio Charts.

News Palisade Bio Inc

Form EFFECT - Notice of Effectiveness
Montag 20 Mai 2024 (1 Tag vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 17 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update
Dienstag 14 Mai 2024 (7 Tage vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 10 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Mittwoch 8 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Palisade Bio Appoints Margery Fischbein to its Board of Directors
Dienstag 7 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
Dienstag 7 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
Donnerstag 2 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)
Mittwoch 1 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Weitere Palisade Bio Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen